| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TAP complex binding | 4.96e-05 | 9 | 24 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 4.96e-05 | 9 | 24 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 6.19e-05 | 10 | 24 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 6.19e-05 | 10 | 24 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 6.19e-05 | 10 | 24 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 9.07e-05 | 12 | 24 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.86e-04 | 17 | 24 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.60e-04 | 20 | 24 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 6.72e-04 | 32 | 24 | 2 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 9.19e-04 | 161 | 24 | 3 | GO:0051087 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 9.98e-04 | 39 | 24 | 2 | GO:0031369 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.16e-03 | 42 | 24 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.57e-03 | 49 | 24 | 2 | GO:0042605 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.70e-03 | 51 | 24 | 2 | GO:0003743 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.20e-03 | 58 | 24 | 2 | GO:0042287 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 4.65e-03 | 85 | 24 | 2 | GO:0008135 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 7.94e-03 | 112 | 24 | 2 | GO:0090079 | |
| GeneOntologyMolecularFunction | ribosome binding | 9.07e-03 | 120 | 24 | 2 | GO:0043022 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.62e-05 | 8 | 24 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | formation of cytoplasmic translation initiation complex | 1.35e-04 | 15 | 24 | 2 | GO:0001732 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.54e-04 | 16 | 24 | 2 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.75e-04 | 17 | 24 | 2 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.75e-04 | 17 | 24 | 2 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.96e-04 | 18 | 24 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.96e-04 | 18 | 24 | 2 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.23e-04 | 23 | 24 | 2 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 3.83e-04 | 25 | 24 | 2 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 3.83e-04 | 25 | 24 | 2 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 6.30e-04 | 32 | 24 | 2 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 1.03e-03 | 41 | 24 | 2 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.09e-03 | 42 | 24 | 2 | GO:0001916 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.87e-05 | 7 | 25 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 4.92e-05 | 9 | 25 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 6.14e-05 | 10 | 25 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 1.24e-04 | 14 | 25 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 1.63e-04 | 16 | 25 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.85e-04 | 17 | 25 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 2.08e-04 | 18 | 25 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 2.32e-04 | 19 | 25 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 2.57e-04 | 20 | 25 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 3.42e-04 | 23 | 25 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 4.38e-04 | 26 | 25 | 2 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 7.97e-04 | 35 | 25 | 2 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.15e-03 | 42 | 25 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.50e-03 | 48 | 25 | 2 | GO:0098576 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.65e-03 | 64 | 25 | 2 | GO:0012507 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 4.40e-03 | 83 | 25 | 2 | GO:0030670 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.61e-03 | 85 | 25 | 2 | GO:0005801 | |
| MousePheno | abnormal hallux morphology | 1.23e-05 | 5 | 16 | 2 | MP:0009049 | |
| MousePheno | spinal cord inflammation | 3.43e-05 | 8 | 16 | 2 | MP:0030987 | |
| MousePheno | head spot | 5.50e-05 | 10 | 16 | 2 | MP:0002939 | |
| MousePheno | decreased immature NK cell number | 1.11e-04 | 14 | 16 | 2 | MP:0013666 | |
| MousePheno | decreased mature NK cell number | 1.86e-04 | 18 | 16 | 2 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 2.08e-04 | 19 | 16 | 2 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 2.08e-04 | 19 | 16 | 2 | MP:0013699 | |
| MousePheno | cystolithiasis | 2.80e-04 | 22 | 16 | 2 | MP:0011625 | |
| MousePheno | decreased NK cell number | 3.18e-04 | 120 | 16 | 3 | MP:0008045 | |
| MousePheno | abnormal mature NK cell number | 3.34e-04 | 24 | 16 | 2 | MP:0013671 | |
| MousePheno | increased alpha-beta T cell number | 3.54e-04 | 311 | 16 | 4 | MP:0012764 | |
| MousePheno | abnormal mature NK cell morphology | 3.63e-04 | 25 | 16 | 2 | MP:0013700 | |
| MousePheno | urolithiasis | 5.60e-04 | 31 | 16 | 2 | MP:0005360 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | 8.40e-04 | 391 | 16 | 4 | MP:0008073 | |
| MousePheno | abnormal NK cell number | 9.11e-04 | 172 | 16 | 3 | MP:0008043 | |
| MousePheno | belly spot | 9.81e-04 | 41 | 16 | 2 | MP:0000373 | |
| MousePheno | abnormal NK cell morphology | 1.09e-03 | 183 | 16 | 3 | MP:0005068 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 1.18e-03 | 45 | 16 | 2 | MP:0004804 | |
| MousePheno | abnormal CD4-positive, alpha beta T cell morphology | 1.27e-03 | 437 | 16 | 4 | MP:0002432 | |
| MousePheno | decreased gamma-delta T cell number | 1.29e-03 | 47 | 16 | 2 | MP:0008347 | |
| MousePheno | white spotting | 1.46e-03 | 50 | 16 | 2 | MP:0002938 | |
| MousePheno | increased lymphocyte cell number | 1.53e-03 | 797 | 16 | 5 | MP:0005013 | |
| MousePheno | CNS inflammation | 1.70e-03 | 54 | 16 | 2 | MP:0006082 | |
| MousePheno | increased T cell number | 1.73e-03 | 475 | 16 | 4 | MP:0005015 | |
| MousePheno | decreased CD8-positive, alpha-beta T cell number | 1.80e-03 | 218 | 16 | 3 | MP:0008079 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 2.40e-03 | 241 | 16 | 3 | MP:0008074 | |
| MousePheno | abnormal gamma-delta T cell number | 2.76e-03 | 69 | 16 | 2 | MP:0008345 | |
| MousePheno | abnormal alpha-beta T cell number | 2.80e-03 | 542 | 16 | 4 | MP:0012763 | |
| MousePheno | abnormal gamma-delta T cell morphology | 3.51e-03 | 78 | 16 | 2 | MP:0008343 | |
| MousePheno | increased NK cell number | 3.87e-03 | 82 | 16 | 2 | MP:0008044 | |
| MousePheno | demyelination | 4.15e-03 | 85 | 16 | 2 | MP:0000921 | |
| MousePheno | abnormal effector T cell morphology | 4.79e-03 | 629 | 16 | 4 | MP:0002435 | |
| MousePheno | abnormal alpha-beta T cell morphology | 5.10e-03 | 640 | 16 | 4 | MP:0012762 | |
| MousePheno | decreased alpha-beta T cell number | 5.10e-03 | 315 | 16 | 3 | MP:0012765 | |
| Domain | EIF3C_N_dom | 1.72e-06 | 2 | 25 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 1.72e-06 | 2 | 25 | 2 | PF05470 | |
| Domain | EIF3C | 1.72e-06 | 2 | 25 | 2 | IPR027516 | |
| Domain | MHC_I_a_C | 2.57e-05 | 6 | 25 | 2 | IPR010579 | |
| Domain | MHC_I_C | 2.57e-05 | 6 | 25 | 2 | PF06623 | |
| Domain | KRAB | 9.75e-05 | 358 | 25 | 5 | PS50805 | |
| Domain | KRAB | 9.75e-05 | 358 | 25 | 5 | PF01352 | |
| Domain | KRAB | 1.12e-04 | 369 | 25 | 5 | SM00349 | |
| Domain | KRAB | 1.14e-04 | 370 | 25 | 5 | IPR001909 | |
| Domain | PINT | 2.04e-04 | 16 | 25 | 2 | SM00088 | |
| Domain | PCI | 2.31e-04 | 17 | 25 | 2 | PF01399 | |
| Domain | PCI_dom | 2.31e-04 | 17 | 25 | 2 | IPR000717 | |
| Domain | MHC_I_a_a1/a2 | 3.56e-04 | 21 | 25 | 2 | IPR001039 | |
| Domain | MHC_I | 3.56e-04 | 21 | 25 | 2 | PF00129 | |
| Domain | zf-C2H2_6 | 7.50e-04 | 314 | 25 | 4 | PF13912 | |
| Domain | - | 1.82e-03 | 679 | 25 | 5 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.99e-03 | 693 | 25 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.00e-03 | 694 | 25 | 5 | IPR013087 | |
| Domain | WW_dom | 2.19e-03 | 52 | 25 | 2 | IPR001202 | |
| Domain | C1-set | 2.36e-03 | 54 | 25 | 2 | PF07654 | |
| Domain | IGc1 | 2.53e-03 | 56 | 25 | 2 | SM00407 | |
| Domain | Ig_C1-set | 2.72e-03 | 58 | 25 | 2 | IPR003597 | |
| Domain | Ig/MHC_CS | 2.72e-03 | 58 | 25 | 2 | IPR003006 | |
| Domain | IG_MHC | 2.90e-03 | 60 | 25 | 2 | PS00290 | |
| Domain | ZINC_FINGER_C2H2_2 | 3.23e-03 | 775 | 25 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 3.27e-03 | 777 | 25 | 5 | PS00028 | |
| Domain | TPR-like_helical_dom | 3.60e-03 | 233 | 25 | 3 | IPR011990 | |
| Domain | Znf_C2H2-like | 3.62e-03 | 796 | 25 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 3.80e-03 | 805 | 25 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 3.86e-03 | 808 | 25 | 5 | SM00355 | |
| Domain | SH3_9 | 4.85e-03 | 78 | 25 | 2 | PF14604 | |
| Domain | SH3_1 | 2.01e-02 | 164 | 25 | 2 | PF00018 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 5.51e-05 | 9 | 18 | 2 | MM14527 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 2.33e-04 | 18 | 18 | 2 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.89e-04 | 20 | 18 | 2 | MM1374 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 4.54e-04 | 25 | 18 | 2 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 4.54e-04 | 25 | 18 | 2 | MM15713 | |
| Pathway | WP_TRANSLATION_FACTORS | 1.89e-03 | 51 | 18 | 2 | MM15881 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.04e-03 | 53 | 18 | 2 | MM14566 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.12e-03 | 54 | 18 | 2 | MM14871 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.28e-03 | 56 | 18 | 2 | MM15901 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.96e-03 | 64 | 18 | 2 | M26953 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | 3.05e-03 | 65 | 18 | 2 | MM15416 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 4.96e-07 | 2 | 25 | 2 | 36157221 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 10504338 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 6411351 | ||
| Pubmed | Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex. | 7.43e-06 | 6 | 25 | 2 | 2740345 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 6961454 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 7.43e-06 | 6 | 25 | 2 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 7.43e-06 | 6 | 25 | 2 | 3940270 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 7836920 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 8283431 | ||
| Pubmed | QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. | 7.43e-06 | 6 | 25 | 2 | 12389096 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 2416805 | ||
| Pubmed | Occurrence of a unique MHC class I gene in distantly related members of the genus Mus. | 7.43e-06 | 6 | 25 | 2 | 3988322 | |
| Pubmed | Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes. | 7.43e-06 | 6 | 25 | 2 | 2580784 | |
| Pubmed | Recognition of alternate alleles and mapping of the Qa1 locus. | 7.43e-06 | 6 | 25 | 2 | 7276576 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 2228044 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 6304710 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 6822734 | ||
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 7.43e-06 | 6 | 25 | 2 | 30537346 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 8732475 | ||
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 7.43e-06 | 6 | 25 | 2 | 6420070 | |
| Pubmed | Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain. | 7.43e-06 | 6 | 25 | 2 | 26040564 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 28894277 | ||
| Pubmed | Identification of a recombinogenic major histocompatibility complex Q gene with diverse alleles. | 7.43e-06 | 6 | 25 | 2 | 8496692 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 3925004 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 9368027 | ||
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 7.43e-06 | 6 | 25 | 2 | 6276751 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 9730897 | ||
| Pubmed | Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. | 7.43e-06 | 6 | 25 | 2 | 6399516 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 2767053 | ||
| Pubmed | Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1d. | 7.43e-06 | 6 | 25 | 2 | 6978819 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 6967411 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 7026427 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2592022 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 1348042 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 6088985 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 1686840 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 1705528 | ||
| Pubmed | Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. | 1.04e-05 | 7 | 25 | 2 | 10023770 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 6143316 | ||
| Pubmed | Manufacture of a functional cDNA for the H-2Db molecule using a retroviral shuttle vector. | 1.04e-05 | 7 | 25 | 2 | 1713192 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2808323 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 9770513 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 7225204 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 21088134 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 1.04e-05 | 7 | 25 | 2 | 19346486 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 34181639 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 69663 | ||
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 1.04e-05 | 7 | 25 | 2 | 18383043 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 8206527 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 16272298 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 1.04e-05 | 7 | 25 | 2 | 12459592 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 19195028 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 1.04e-05 | 7 | 25 | 2 | 6956903 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 8833240 | ||
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 1.04e-05 | 7 | 25 | 2 | 6264319 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 1.04e-05 | 7 | 25 | 2 | 6604582 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 6815535 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 3456611 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 15809355 | ||
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 1.04e-05 | 7 | 25 | 2 | 2714856 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 10500200 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 16473882 | ||
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 1.04e-05 | 7 | 25 | 2 | 6954478 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 16210630 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 10479061 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 12902470 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 1.04e-05 | 7 | 25 | 2 | 2391419 | |
| Pubmed | Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands. | 1.04e-05 | 7 | 25 | 2 | 24154624 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 34525366 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 3838699 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 1740659 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 3374494 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 1.04e-05 | 7 | 25 | 2 | 3840195 | |
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 1.04e-05 | 7 | 25 | 2 | 3025084 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2543831 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 15671142 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 14215561 | ||
| Pubmed | Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. | 1.04e-05 | 7 | 25 | 2 | 1540549 | |
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 1.04e-05 | 7 | 25 | 2 | 2909618 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 1.04e-05 | 7 | 25 | 2 | 11894934 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 19700752 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 1.04e-05 | 7 | 25 | 2 | 28234229 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 11894963 | ||
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 1.04e-05 | 7 | 25 | 2 | 6242891 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 16836618 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 22287714 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 17512611 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 3997208 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2989712 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 3263465 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 7018573 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 1.04e-05 | 7 | 25 | 2 | 1280760 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 2997361 | ||
| Pubmed | Expression of GM1 and GD1a in mouse liver is linked to the H-2 complex on chromosome 17. | 1.04e-05 | 7 | 25 | 2 | 6671979 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 1.04e-05 | 7 | 25 | 2 | 6786753 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 6583704 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 18974374 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 8168857 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 20534453 | ||
| Interaction | ZNF763 interactions | 2.21e-05 | 6 | 25 | 2 | int:ZNF763 | |
| Cytoband | 19p13.2 | 7.03e-06 | 229 | 25 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 8.53e-04 | 797 | 25 | 4 | chr19p13 | |
| Cytoband | 16p11.2 | 4.85e-03 | 191 | 25 | 2 | 16p11.2 | |
| Cytoband | 6p21.3 | 8.16e-03 | 250 | 25 | 2 | 6p21.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.18e-04 | 718 | 20 | 5 | 28 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.07e-03 | 44 | 20 | 2 | 588 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_B_CELL_AGEING | 3.89e-07 | 311 | 25 | 6 | MM3674 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 3.89e-05 | 203 | 25 | 4 | MM3795 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.04e-04 | 16 | 25 | 2 | MM3766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.27e-04 | 103 | 25 | 3 | MM476 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.48e-04 | 19 | 25 | 2 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.48e-04 | 19 | 25 | 2 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.64e-04 | 20 | 25 | 2 | MM3682 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.81e-04 | 302 | 25 | 4 | MM16604 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.81e-04 | 21 | 25 | 2 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 2.38e-04 | 24 | 25 | 2 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.59e-04 | 25 | 25 | 2 | MM672 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Papillary-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.26e-07 | 111 | 25 | 4 | eb737146969b70c619649f244998d4183237c763 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.18e-06 | 167 | 25 | 4 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Papillary|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.59e-05 | 115 | 25 | 3 | f02675a5ee12cb35535f82433d7f3f3e8349a677 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.87e-05 | 143 | 25 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.01e-05 | 144 | 25 | 3 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.06e-05 | 157 | 25 | 3 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.23e-05 | 158 | 25 | 3 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 1.05e-04 | 165 | 25 | 3 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.11e-04 | 168 | 25 | 3 | d50078614f7af74dc2aa4081c1708a5156ac51cf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 181 | 25 | 3 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.40e-04 | 182 | 25 | 3 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.43e-04 | 183 | 25 | 3 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.43e-04 | 183 | 25 | 3 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 185 | 25 | 3 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.47e-04 | 185 | 25 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.57e-04 | 189 | 25 | 3 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 191 | 25 | 3 | c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.64e-04 | 192 | 25 | 3 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | BL-critical-LOC-Epithelial-unknown_epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 194 | 25 | 3 | 6140ff8e776429c9593607da418b2d9c4f399d41 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.85e-04 | 200 | 25 | 3 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| Disease | Premature atrial contractions | 1.37e-05 | 55 | 25 | 3 | HP_0006699 | |
| Disease | susceptibility to cold sores measurement | 1.39e-03 | 65 | 25 | 2 | EFO_0008402 | |
| Disease | skin neoplasm | 1.79e-03 | 74 | 25 | 2 | EFO_0004198 | |
| Disease | interleukin 18 measurement | 1.89e-03 | 76 | 25 | 2 | EFO_0004581 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.26e-03 | 355 | 25 | 3 | EFO_0004784, EFO_0008354 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 4.48e-03 | 118 | 25 | 2 | EFO_0010119 | |
| Disease | keratinocyte carcinoma | 4.48e-03 | 118 | 25 | 2 | EFO_0010176 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 4.78e-03 | 122 | 25 | 2 | EFO_0009264, EFO_0010724 | |
| Disease | Squamous cell carcinoma | 4.93e-03 | 124 | 25 | 2 | C0007137 | |
| Disease | docosahexaenoic acid measurement | 5.17e-03 | 127 | 25 | 2 | EFO_0007761 | |
| Disease | forced expiratory volume, response to bronchodilator | 6.12e-03 | 445 | 25 | 3 | EFO_0004314, GO_0097366 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 6.59e-03 | 144 | 25 | 2 | EFO_0004611, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYEQHAYDGKDYIAL | 136 | P01893 | |
| YHSGNDVEAYEYLNK | 351 | Q9Y5A7 | |
| DGQEAEGKYEEYGYN | 106 | Q9HCQ5 | |
| KSCQHNYYEDAKAYG | 701 | Q6UVM3 | |
| GHDQYAYDGKDYIAL | 136 | P01889 | |
| KHVDDQGRQYYYSAD | 366 | Q8IWW6 | |
| CQEEHKNQGYYDYVK | 956 | Q02218 | |
| HKQGTYGGYFRDQKD | 876 | Q99613 | |
| DHKQGTYGGYFRDQK | 876 | B5ME19 | |
| DYQYVGKLHSDQDKG | 71 | Q9Y6N8 | |
| YYNKDNKGNDEHEAG | 441 | Q14993 | |
| YEYGSIEKVKNGYVN | 266 | Q9UMX9 | |
| AQAYLDKYYTNKEGH | 41 | O60882 | |
| KIGDYHYYGYGTKKD | 556 | Q5TEA6 | |
| RGDIGHKAYEYQEYG | 126 | Q8IYI8 | |
| YDGKYEKTLYGHNLE | 71 | Q86VZ2 | |
| HESQQDYSKGFGGKY | 296 | Q14247 | |
| GDIYNEKGYYNKASE | 361 | Q8NA56 | |
| YQVDYDNHALYKHGK | 336 | Q9H5U6 | |
| RGDIGHKAYEYQEYG | 146 | Q9UC07 | |
| FDEYQKIHTGGKNYE | 186 | Q6P280 | |
| RGDIGHKAYEYQDYA | 126 | Q0D2J5 | |
| QKEYSKNYGKYEEGN | 246 | Q8NG68 | |
| DTGHKAYEYQEYGQK | 126 | Q8N7K0 | |
| IAKDKNYGSYYGVGD | 321 | Q12836 |